These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31876059)

  • 1. The antitumour activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole in human gastric cancer models is mediated by AhR signalling.
    Wang Y; Liu Y; Tang T; Luo Y; Stevens MFG; Cheng X; Yang Y; Shi D; Zhang J; Bradshaw TD
    J Cell Mol Med; 2020 Jan; 24(2):1750-1759. PubMed ID: 31876059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.
    Trapani V; Patel V; Leong CO; Ciolino HP; Yeh GC; Hose C; Trepel JB; Stevens MF; Sausville EA; Loaiza-Pérez AI
    Br J Cancer; 2003 Feb; 88(4):599-605. PubMed ID: 12592376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.
    McLean LS; Watkins CN; Campbell P; Zylstra D; Rowland L; Amis LH; Scott L; Babb CE; Livingston WJ; Darwanto A; Davis WL; Senthil M; Sowers LC; Brantley E
    Chem Res Toxicol; 2015 May; 28(5):855-71. PubMed ID: 25781201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
    Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
    Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines.
    Bradshaw TD; Stone EL; Trapani V; Leong CO; Matthews CS; te Poele R; Stevens MF
    Breast Cancer Res Treat; 2008 Jul; 110(1):57-68. PubMed ID: 17674193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles.
    Leong CO; Suggitt M; Swaine DJ; Bibby MC; Stevens MF; Bradshaw TD
    Mol Cancer Ther; 2004 Dec; 3(12):1565-75. PubMed ID: 15634650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells.
    Brantley E; Antony S; Kohlhagen G; Meng L; Agama K; Stinson SF; Sausville EA; Pommier Y
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):62-72. PubMed ID: 16331501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.
    Bazzi R; Bradshaw TD; Rowlands JC; Stevens MF; Bell DR
    Toxicol Appl Pharmacol; 2009 May; 237(1):102-10. PubMed ID: 19265716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells.
    Luzzani GA; Callero MA; Kuruppu AI; Trapani V; Flumian C; Todaro L; Bradshaw TD; Loaiza Perez AI
    J Cell Biochem; 2017 Dec; 118(12):4526-4535. PubMed ID: 28471540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of sensitivity to potent and selective antitumor 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F203) in ovarian cancer.
    Callero MA; Luzzani GA; De Dios DO; Bradshaw TD; Perez AI
    J Cell Biochem; 2013 Oct; 114(10):2392-404. PubMed ID: 23696052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
    Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
    Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
    Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
    Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death.
    Rowland LK; Campbell PS; Mavingire N; Wooten JV; McLean L; Zylstra D; Thorne G; Daly D; Boyle K; Whang S; Unternaehrer J; Brantley EJ
    J Cell Biochem; 2019 Apr; 120(4):6004-6014. PubMed ID: 30450577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo.
    Leong CO; Gaskell M; Martin EA; Heydon RT; Farmer PB; Bibby MC; Cooper PA; Double JA; Bradshaw TD; Stevens MF
    Br J Cancer; 2003 Feb; 88(3):470-7. PubMed ID: 12569393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth.
    Yin XF; Chen J; Mao W; Wang YH; Chen MH
    J Exp Clin Cancer Res; 2012 May; 31(1):46. PubMed ID: 22592002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole.
    Monks A; Harris E; Hose C; Connelly J; Sausville EA
    Mol Pharmacol; 2003 Mar; 63(3):766-72. PubMed ID: 12606787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxifolin suppresses the malignant progression of gastric cancer by regulating the AhR/CYP1A1 signaling pathway.
    Xie J; Pang Y; Wu X
    Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34490474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
    Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF
    Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
    Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
    Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.